A detailed history of Westover Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 2,122 shares of LLY stock, worth $1.69 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
2,122
Previous 1,943 9.21%
Holding current value
$1.69 Million
Previous $1.76 Million 6.82%
% of portfolio
0.37%
Previous 0.46%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $138,213 - $171,843
179 Added 9.21%
2,122 $1.88 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $19,571 - $24,544
27 Added 1.41%
1,943 $1.76 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $180,665 - $212,980
-344 Reduced 15.22%
1,916 $1.12 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $350 - $468
-1 Reduced 0.04%
2,260 $1.06 Million
Q1 2023

May 22, 2023

BUY
$310.63 - $364.82 $621 - $729
2 Added 0.09%
2,261 $776,000
Q4 2022

May 18, 2023

SELL
$321.55 - $374.67 $15,112 - $17,609
-47 Reduced 2.04%
2,259 $826,000
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $1,083 - $1,401
-6 Reduced 0.26%
2,306 $529,000
Q1 2021

May 18, 2021

SELL
$164.32 - $212.72 $6,572 - $8,508
-40 Reduced 1.7%
2,312 $432,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $26,092 - $34,526
200 Added 9.29%
2,352 $397,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $63,708 - $76,672
467 Added 27.72%
2,152 $353,000
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $180,160 - $223,144
1,685 New
1,685 $221,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $186,681 - $217,904
-1,685 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $187,557 - $220,768
1,685 New
1,685 $219,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Westover Capital Advisors, LLC Portfolio

Follow Westover Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westover Capital Advisors, LLC with notifications on news.